We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $205.96 today based on a ...

In a report released today, Vamil Divan from Guggenheim maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target of ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like ...

A significant trading signal occurred for AbbVie stock at $164.86, ahead of tariff reversal news. ABBV climbed up to 9.2% ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on AbbVie (ABBV – Research Report) today and set a price target of $239.00. The ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Merck MRK and AbbVie ABBV are leading pharmaceutical companies with strong portfolios in oncology and immunology. While ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...